The Indian haematology instruments and reagents market in 2018 is estimated as Rs 790 crore. Reagents constitute 63.3 percent of the market at Rs 500 crore, and instrument the balance at Rs 290 crore.
The haematology instruments market may be segmented as 5-part and 3-part analysers. By quantity, in 2018, the 3-part analysers dominated with an estimated 85 percent market share, albeit the margins continued to come from the 5-part analysers. Within the 3-part analyser segment, the single-chamber is a dying breed and the laboratories are opting for its double-chamber counterpart. Within the 5-part analysers, the entry-level analysers are more popular. The maximum growth is being seen by the 5-part entry-level analysers.
The Indian healthcare & Diagnostic industry currently faces problem pertaining to the access of diagnostic healthcare in rural India due to lack of technology integration and affordability. The infrastructure is also an issue as there is a lack of well-functioning, licensed laboratory services; the ones present are marred with shortages of pathologists, technicians, biochemists, and other staff. Rural India has one-fourth the doctors and diagnostic facilities as compared to urban areas affecting the chronically ill, who require complex and expensive long-term monitoring and treatment strategies.
Development of precise, flexible, and user-friendly technologies that are cost-effective has been a trend in the haematology market. Advancement in research has led to more professional demands and capabilities in these units of testing.
Today with rise in population and growing healthcare need, India needs 15,000-20,000 blood cell counter machines to serve both urban and rural India, majority of these analyzers are imported from US, Japan, China and Europe. The cost of imported machines and consumables are high which directly or indirectly impact the patient spending.
Agappe Diagnostics Ltd, India’s largest manufacturer of Immunochemistry reagent and nephelometry analysers have launched an indigenously developed blood cell counter Mispa Count X, in partnership with L&T Technology Services (LTTS). With its strong R&D Capabilities Agappe have designed a totally Made In India haematology analyser with advanced technologies to support patient care, by delivering the right results at the most affordable cost. Foundational to the system its core technologies include smart impedance technology, the features offer cell counting and precise cellular assessment for excellent red blood cell, platelet and white blood cell. The count x technologies are intended to help laboratories deliver quality results for fast, accurate clinical decision-making. At the same time, the system includes touch screen enabled system to streamline the number of procedural steps needed check flags and measure cell count thus offering predictable performance and greater laboratory efficiency. The technology generates reportable results as quickly as 60 test / hr, reducing the time, supplies and costs that may be required for systems with higher repeat rates. Further, Mispa count x features one of the smallest footprints and in its class, making it highly efficient in utilization of laboratory space. Many of the parameters available with count x analyser are designed to directly impact patient care by addressing critical conditions, such as thrombocytopenia, and anemia is another often-deadly condition that affects millions of people in India each year.Accurate Reliable Mispa Count X is a compact hematology system and provides 20 hematology parameters, with 3 Histogram . The Count x Smart technology requires micro-sampling of 14 µL of whole blood and 20 µL of prediluted to run any mode of blood sample. HighTech Laser cut Ruby aperture of 70 micron for RBC - Platelet and 100 Micron for WBC, The facets of brilliant cut gems Known for its strength and high precision is designed to offer better impedance and to offer interference free quality result.
Agappe also holds the position of largest haematology reagent manufacturing capabilities in Asia Pacific with more than 20,000 Litre per batch. Mispa count x reagent is designed to deliver most accurate results at most affordable cost per test which will be the lowest as compared to other analysers in same segment. The Count x will provide a high level of continuity of care for clinical laboratories, regardless of whether they are small- or high-volume facilities, with count x Agappe aims to 55,000-60,000 laboratories in India provide accurate diagnostics.
